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Abstract
Background:  Depression is associated with risk for chronic disease, though its relationship 
with infectious diseases is less understood. Depression may modify the clinical outcomes of 
patients with infectious diseases such as influenza via its association with inflammation. The 
objective of this study was to evaluate the relationships between depression and clinical out-
comes in non-elderly adults with influenza infection.
Methods:  This was a secondary analysis of the Nationwide Inpatient Sample database, years 
2012-2016. Hospitalized adults aged 18-65 admitted during each influenza season were includ-
ed. Depression status was documented via ICD-10 codes. The association between depression 
and clinical outcomes (e.g. disease severity, length of hospital stay, and inpatient all-cause 
mortality) were evaluated using multivariable regression modeling.
Results:  A total of 44,292 patients were included, 12% with depression. After adjustment for 
confounding, non-elderly influenza patients with depression had a 3.8% decreased risk of a 
severe disease (95% CI: 1.9% - 5.7%; P<0.001), no difference in length of stay (Hazard Ratio: 
0.99, 95% Confidence Interval 0.96 – 1.02), and lower all-cause in-hospital mortality versus 
those without depression (Odds Ratio=0.76; 95% CI 0.59 - 0.97; P=0.028).
Conclusions:  This study suggests that in non-elderly hospitalized patients with influenza, 
depression is associated with a decreased severity of illness and acute mortality. Chronic in-
flammation in those with depression may enhance the ability of the immune response to limit 
influenza infection or reduce pathologic acute inflammation associated with influenza disease. 
Introduction
Major depression is a well established risk factor for chronic disease and adverse out-
comes in comorbid patients. [1]  Among the most studied are the relationships between 
depression and increased risk for incident cardiovascular disease [1, 2] and type-2 dia-
betes [3, 4].  In comparison, the literature on depression and infectious diseases is less 
developed. Depression is associated with a significantly increased acquisition of the 
common cold [5], Clostridium (Clostridioides) difficile infection following total knee re-
placement surgery [6], bloodstream infection [7], enterovirus infection [8], and is asso-
ciated with increased risk of infection following elective shoulder arthroplasty [9]. To 
date, there is limited evidence of the impact of depression on influenza illness and out-
comes, though a review of the sparse literature concluded that there is an absence of 
evidence to support or refute a link between depression and risk for influenza acqui-
sition. [10] There is strong support for an immunologic dysregulation in many patients 
with depression which could explain some of these increased risks. Depression-related 
immune dysregulation is also associated with a blunted response to vaccines as well as 
delayed immunity. [11, 12] Patients with depression have increased pro-inflammatory cy-
tokines (e.g. Interleukin 6, Tumor Necrosis Factor alpha) [13, 14] resulting in release of 
acute phase proteins, chemokines, and adhesion molecules [15]; immune cell differenti-
ation and recruitment; and a wide array of other impacts on the human body [16].  Given 
depression is associated with a dysregulated immune state, depressed patients may have 
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a differential disease severity or outcome after infection as well.
Understanding the relationships between depression and influenza is critical. Nearly 21% of adults in the United States 
will experience a major depressive episode in their lifetime [17] and depression is now the leading cause of disabili-
ty worldwide [18].  Further, influenza results in substantial morbidity and mortality globally each year and influenza 
research is often limited to only the elderly population, leaving a dearth of evidence in non-elderly populations. [19] 
Further research is warranted to determine if this common mental illness is associated with increased severity of, or 
poor outcomes in patients with influenza infection. The objective of this study was to evaluate the association between 
depression and influenza severity and clinical outcomes in non-elderly adult patients hospitalized with influenza in 
the United States. 
Methods
Study Design 
This was a secondary analysis of data from the National Inpatient Sample (NIS), Healthcare Cost and Utilization Proj-
ect (HCUP), Agency for Healthcare Research and Quality. This database contains is a 20% stratified sample of approx-
imately 6-8 million hospital discharges per year. [20] 
Subjects:  Inclusion/Exclusion Criteria
Inpatient stays of individuals aged 18 – 64 with a discharge diagnosis code (ICD-9 or ICD-10) for influenza, from 2012 
through 2016 were included in the analysis. Data were limited to months during the peak months of the typical influ-
enza season in the United States (November through March). Patients without an all patient refined diagnosis related 
group (APR-DRG) severity or mortality risk subclass were excluded from analysis. 




•	 Depression – Patients were classified as having depression if they had an ICD-9/10 code for depression diagnoses 
on discharge (see the Supplementary Appendix for detailed codes). 
Outcomes:
•	 Severity – Severity of illness was defined using the all patient refined diagnosis related group (APR-DRG) severity 
measure as documented in the NIS database. [21] This measure reflects the extent of a patient’s physiologic de-
compensation or loss of organ system function and is calculated through passing diagnosis and procedure codes 
through a complex multiphase algorithm developed by 3M Health Information Systems. The APR-DRG severity 
was dichotomized into severe (Major or Extreme Loss of Function) versus non severe (Minor or Moderate Loss of 
Function).
•	 Length of Stay – Length of stay was defined as the number of days from admission to discharge or death.
•	 Mortality – Mortality was defined as all-cause inpatient mortality before discharge as documented in the NIS da-
tabase. 
Covariates
The following variables were selected for adjustment in regression modeling due to their potential confounding ef-
fects: Age (restricted cubic spline with 4 knots), gender, ICD-9/ICD-10 codes for diagnosis of pneumonia, nicotine 
dependence, anxiety disorder, and alcohol use disorder (see Appendix for detailed definitions), APR-DRG Severity (for 
mortality and length of stay models), APR-DRG mortality risk [21], quartile of median household income of patients zip 
code of residence, and 2017 AHRQ Elixhauser Weighted Comorbidity Index [22].
Statistical Analysis
Categorical variables were described with frequencies and percentages, while continuous variables were described 
with means and standard deviations or medians with interquartile ranges, as appropriate. Bivariable comparisons be-
tween depressed and non-depressed patients were made using Chi-squared or Fisher’s Exact tests, while independent 
samples t-tests or Mann-Whitney U-tests were used to compare differences in continuous variables. 
To define the adjusted impact of depression on disease severity, a multivariable Poisson regression model with a ro-
bust error estimator was used. [23] In this model, independent variables included: presence of pneumonia, a restrict-
ed cubic spline with 4 knots of the patient’s age, nicotine dependence, anxiety disorder, gender, alcohol use disorder, 
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APR-DRG risk of mortality,  the quartile of median household income of the patients zip code of primary residence, 
and the weighted version of the grouped Elixhauser Comorbidity Index using the Agency for Healthcare Research and 
Quality (AHRQ) algorithm. [22]  To assess the adjusted impact of depression on length of hospital stay and account for 
patients who died before discharge, competing risks regression was used. [24]  All variables described above, as well as 
the severity of illness (APR-DRG Severity) were used for adjustment. To assess the impact of depression on in-hospital 
mortality, a multivariable logistic regression model was used. The same variables as documented for the length of stay 
model were included as covariates. Variance inflation factors, tolerance statistics, and correlation coefficients were 
used to evaluate the presence of multicollinearity before all regression modeling. R v3.6.1 (R Foundation for Statistical 
Computing, Vienna Austria) was used for all analyses.
Results
A total of 42,540 hospitalized adult, non-elderly patients with influenza were included in the analysis; 4,952 (12%) with 
a diagnosis code for depression and 37,588 (88%) without. Baseline socio-demographic and clinical features of patients 
stratified by the presence or absence of depression diagnosis can be seen in Table 1. 
Several statistically significant differences in characteristics were identified between depressed and non-depressed 
hospitalized non-elderly adults with influenza. Depressed patients were slightly older (mean age 50.7 (SD ±10.7) years) 
compared to patients without depression (mean age 47.4 years (SD ±12.8, P<0.001).  Patients with depression vs. those 
without were more likely to be female (66% vs 54%, P<0.001), have nicotine dependence (41% vs 32%, P<0.001), have 
alcohol use disorder (5% vs 4% (P=0.001), and an anxiety disorder (41% vs 9%, p<0.001).  Depressed patients had a de-
creased unadjusted mortality versus non depressed patients (1.7% vs 2.7%, P<0.001).
As depicted in Table 2, non-elderly influenza patients with depression were found to have a 3.8% decreased adjusted 
risk of a major or severe loss of function versus those without depression (95% CI: 1.9% - 5.7%; P<0.001). Table 3 re-
Table 1. Baseline characteristics of adult, non-elderly inpatients with influenza, November - 





Age, mean (SD) 50.72 (10.69) 47.41 (12.83) <0.001
Female gender, n (%) 3286 (66.4) 20321 (54.1) <0.001
Pneumonia, n (%) 1582 (31.9) 11818 (31.4) 0.481
Nicotine dependence, n (%) 2045 (41.3) 12090 (32.2) <0.001
Alcohol use disorder, n (%) 253 (5.1) 1536 (4.1) 0.001
Anxiety, n (%) 2039 (41.2) 3500 (9.3) <0.001
APRDRG Severity of Illness, n (%)   <0.001
Minor loss of function 446 (9.0) 4990 (13.3)  
Moderate loss of function 1756 (35.5) 14064 (37.4)  
Major loss of function 1917 (38.7) 12370 (32.9)  
Extreme loss of function 833 (16.8) 6164 (16.4)  
APRDRG Risk of Mortality, n (%)   <0.001
Minor likelihood of death 1940 (39.2) 16934 (45.1)  
Moderate likelihood of death 1260 (25.4) 8717 (23.2)  
Major  likelihood of death 1233 (24.9) 7834 (20.8)  
Extreme likelihood of death 519 (10.5) 4103 (10.9)  
Median household income of 
residential zip code, n (%)   <0.001
1 1564 (32.1) 13104 (35.7)  
2 1286 (26.4) 9416 (25.6)  
3 1176 (24.2) 8069 (22.0)  
4 842 (17.3) 6166 (16.8)  
Weighted Elixhauser (AHRQ) 
Index, n (%)   <0.001
<0 2000 (40.4) 5764 (15.3)  
0 195 (3.9) 4205 (11.2)  
1-4 562 (11.3) 5713 (15.2)  
≥5 2195 (44.3) 21906 (58.3)  
• APRDRG: All Patient Refined Diagnosis Related Group
• AHRQ: Agency for Healthcare Research and Quality
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ports the results of competing risks regression for evaluation of adjusted associations between depression and length 
of hospital stay. Non-elderly influenza patients with depression had no change in length of stay (adjusted Hazard Ratio 
of discharge 0.99, 95% Confidence Interval 0.96 – 1.02).  As depicted in Table 4, non-elderly influenza patients with 
depression had lower all-cause in-hospital mortality versus those without depression (adjusted Odds Ratio=0.76; 95% 
CI 0.59 - 0.97; P=0.028).
Discussion
In a large sample of non-elderly hospitalized patients with influenza infection, those with depression diagnoses had 
a decreased risk of more severe disease and a lower odds of inpatient mortality, but showed no difference in length of 
hospital stay. The relationship between depression and severity of disease was statistically significant, but the magni-
tude of the association was small and not likely to be clinically meaningful. This limited impact could be due to more 
severe illness in general regardless of depression status as indicated by the need for hospitalization. This magnitudue 
may be more pronounced in outpatient settings where severity of illness may have a wider distribution. It is also possi-
ble that by selecting a younger age cohort, we have selected for more severe hospitalized influenza cases. 
While the lower risk of mortality in patients with depression is seemingly paradoxical and is in disagreement with one 
study in the Veterans Health Administration [25], the results may be consistent with the pathophysiology of influenza 
mortality. Depression is known to be associated with immune dysregulation, with many individuals suffering from this 
condition having increased baseline pro-inflammatory cytokines (e.g. Interleukin-6), and other inflammatory markers 
[13-15, 26].  Since death due to influenza is often associated with an overexuberant inflammatory response to infection 
rather than an overwhelming disseminated infection [27], patients with an already inflamed state may have negative 
regulatory networks activated which protect against excessive increases in inflammation. This negative feedback may 
prevent severe immunopathologic responses to influenza infection. [28] As an example, patients with lower respiratory 
tract infections such as pneumonia (a common complication of influenza infection) are at increased risk of myocardial 
infarction. [29] This is possibly due to the inflammatory response of the acute respiratory infection dislodging athero-
sclerotic plaques, resulting in infarction. If the inflammatory response post infection is not substantially different from 
Table 2. Results of the multivariable regression model for severity of illness for adult, non-
elderly inpatients with influenza, November - March, 2012-2016 in the United States.
Variable Risk Ratio Lower 95% CI
Upper 
95% CI P-value
Depression 0.96 0.943 0.981 <0.001
Female gender 1.00 0.991 1.016 0.63
Age, spline 1 1.00 0.994 1.001 0.107
Age, spline 2 1.00 0.992 1.007 0.926
Age, spline 3 0.99 0.946 1.044 0.802
Age, spline 4 1.07 0.914 1.245 0.412
Nicotine dependence 0.98 0.968 0.994 0.005
Anxiety 0.96 0.947 0.981 <0.001
Alcohol use disorder 1.00 0.972 1.023 0.82
Pneumonia 1.19 1.175 1.206 <0.001
APR-DRG Mortality Risk Minor REFERENCE - - -
APR-DRG Mortality Risk Moderate 4.51 4.303 4.726 <0.001
APR-DRG Mortality Risk Major 6.96 6.651 7.291 <0.001
APR-DRG Mortality Risk Extreme 6.24 5.939 6.552 <0.001
Median Household Income of Zip Code 
Quartile 1 REFERENCE - - -
Median Household Income of Zip Code 
Quartile 2 1.00 0.987 1.020 0.704
Median Household Income of Zip Code 
Quartile 3 1.02 1.004 1.038 0.017
Median Household Income of Zip Code 
Quartile 4 1.02 0.997 1.035 0.104
Weighted Elixhauser (AHRQ) Index <0 REFERENCE - - -
Weighted Elixhauser (AHRQ) Index 0 0.95 0.927 0.970 <0.001
Weighted Elixhauser (AHRQ) Index 1-4 0.91 0.873 0.954 <0.001
Weighted Elixhauser (AHRQ) Index ≥5 0.97 0.942 1.00 0.048
• APRDRG: All Patient Refined Diagnosis Related Group
• AHRQ: Agency for Healthcare Research and Quality
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Variable Hazard Ratio Lower 95% CI
Upper 
95% CI P-value
Depression 0.99 0.961 1.019 0.470
Female gender 0.97 0.950 0.986 0.001
Age 0.996 0.995 0.996 <0.001
Nicotine dependence 0.75 0.639 0.870 <0.001
Anxiety 1.05 1.029 1.070 0.000
Alcohol use disorder 0.87 0.849 0.897 <0.001
Pneumonia 0.91 0.896 0.932 <0.001
APR-DRG Severity of Illness, Minor REFERENCE - - -
APR-DRG Severity of Illness, Moderate 0.81 0.782 0.832 <0.001
APR-DRG Severity of Illness, Major 0.56 0.535 0.579 <0.001
APR-DRG Severity of Illness, Extreme 0.27 0.259 0.289 <0.001
APR-DRG Mortality Risk Minor REFERENCE - - -
APR-DRG Mortality Risk Moderate 0.91 0.882 0.934 <0.001
APR-DRG Mortality Risk Major 0.84 0.807 0.867 <0.001
APR-DRG Mortality Risk Extreme 0.46 0.434 0.483 <0.001
Median Household Income of Zip Code 
Quartile 1 REFERENCE - - -
Median Household Income of Zip Code 
Quartile 2 1.05 1.023 1.072 <0.001
Median Household Income of Zip Code 
Quartile 3 1.04 1.011 1.062 0.004
Median Household Income of Zip Code 
Quartile 4 1.03 1.003 1.059 0.031
Weighted Elixhauser (AHRQ) Index <0 REFERENCE - - -
Weighted Elixhauser (AHRQ) Index 0 1.01 0.980 1.036 0.590
Weighted Elixhauser (AHRQ) Index 1-4 1.18 1.137 1.229 <0.001
Weighted Elixhauser (AHRQ) Index ≥5 1.10 1.067 1.138 <0.001
• APRDRG: All Patient Refined Diagnosis Related Group
• AHRQ: Agency for Healthcare Research and Quality
Table 3. Results of the multivariable competing risks regression model for length of hospital 
stay (time to discharge) of adult, non-elderly inpatients with influenza, November - March, 
2012-2016 in the United States.
a baseline rate of inflammation, or this cascade is otherwise influenced by the baseline inflammation of a patient with 
depression, this event may not occur, and in-hospital death rates might be reduced. 
Another rationale for our results includes the fact that depression in the NIS database is administratively coded for 
reimbursement on discharge. This means that the disease was significant for care during hospitalization, or was oth-
erwise coded for a complex case. This may increase the likelihood of therapy for depression with various other medi-
cations, some of which could be anti-inflammatory. [30-34]  Anti-inflammatory medications may improve the clinical 
outcomes of these patients similar to the impact of glucocorticoids, macrolide antibiotics, or other anti-inflammatory 
medications in patients with severe respiratory infection. [30-33] If depressed patients receive more anti-inflammatory 
medications than non-depressed patients, inpatient mortality could appear lower. This issue could also inject vari-
ous confounding biases that were uncontrolled. It is also possible that there is a differential threshold for admitting 
a patient with depression and our results could be due to unadjusted artifacts of this issue, also similarly described in 
patients with obesity. [35]
One aspect not evaluated in this study includes the actual risk of influenza acquisition in the presence or absence of de-
pression. The literature on this topic remains inconsistent and is dominated by small samples, with a systematic review 
concluding the quality of evidence does not support concluding there is an increased risk. [10]  However, Segerstrom 
and colleagues revealed evidence that elderly patients with depression had reduced antibody response to multiple in-
fluenza strains compared to those without depression, suggesting a possible increase in risk of influenza acquisition. 
[12] In a separate study in 70 elderly participants, depression was associated with having significantly more influenza 
like symptoms, though this was no longer significant in multivariable analysis. [36]  Without large prospective studies, 
this is likely to remain an unknown.
This study has several limitations.  First, we did not have information on influenza vaccine history. Receipt of the influ-
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Variable Odds Ratio Lower 95% CI
Upper 
95% CI P-value
Depression 0.76 0.594 0.971 0.028
Female gender 1.02 0.892 1.169 0.762
Age, spline 1 1.03 0.993 1.065 0.12
Age, spline 2 0.99 0.910 1.074 0.789
Age, spline 3 1.06 0.618 1.816 0.835
Age, spline 4 0.77 0.146 4.048 0.756
Nicotine dependence 0.75 0.639 0.870 <0.001
Anxiety 0.66 0.525 0.828 <0.001
Alcohol use disorder 1.17 0.900 1.512 0.246
Pneumonia 1.19 1.036 1.368 0.014
APR-DRG Severity of Illness, Minor REFERENCE - - -
APR-DRG Severity of Illness, Moderate 2.08 1.061 4.072 0.033
APR-DRG Severity of Illness, Major 3.93 1.930 8.021 <0.001
APR-DRG Severity of Illness, Extreme 22.2 10.805 45.627 <0.001
APR-DRG Mortality Risk Minor REFERENCE - - -
APR-DRG Mortality Risk Moderate 4.85 0.643 36.640 0.126
APR-DRG Mortality Risk Major 7.99 1.021 62.542 0.048
APR-DRG Mortality Risk Extreme 38.7 4.890 306.602 0.001
Median Household Income of Zip Code 
Quartile 1 REFERENCE - - -
Median Household Income of Zip Code 
Quartile 2 0.91 0.768 1.087 0.308
Median Household Income of Zip Code 
Quartile 3 0.91 0.761 1.090 0.308
Median Household Income of Zip Code 
Quartile 4 0.91 0.746 1.108 0.347
Weighted Elixhauser (AHRQ) Index <0 REFERENCE - - -
Weighted Elixhauser (AHRQ) Index 0 2.02 1.407 2.901 <0.001
Weighted Elixhauser (AHRQ) Index 1-4 1.33 0.737 2.394 0.345
Weighted Elixhauser (AHRQ) Index ≥5 0.99 0.609 1.625 0.983
• APRDRG: All Patient Refined Diagnosis Related Group
• AHRQ: Agency for Healthcare Research and Quality
Table 4. Results of the multivariable regression model for all-cause inpatient mortality of 
adult, non-elderly inpatients with influenza, November - March, 2012-2016 in the United 
States.
enza vaccine is thought to, at minimum, a decreased severity of disease even when infected with influenza. [37] Men-
tal illness has also been associated with failure to obtain vaccines, as well as decrease the immune response to some 
vaccines. [11, 12] Second, we were not able to include information on laboratory values which may be significant in the 
identification of subgroups affected differently by depressive state (e.g. cytokines and acute phase proteins). We also 
did not have information on the cause of death for these individuals. Although often difficult to ascertain, this infor-
mation may assist in identifying subgroups affected differently by depression. Information on the number of days with 
respiratory symptoms before admission was not available in the NIS database. A delay in hospitalization for or with 
influenza will delay treatment. Since therapy with oseltamivir is only effective in the initial days of infection, a delay in 
seeking treatment will result in decreased therapeutic effectiveness resulting in potentially altered clinical outcomes. 
[38] Therefore, if depressed patients had a shorter duration of symptoms before hospitalization, they may be treated 
sooner resulting in improved clinical outcomes. Lack of information on anti-inflammatory medications (e.g. statins, 
steroids, etc) further limits the understanding of the relationship between depression and outcomes if depression is a 
result of hyperinflammation. Further, we did not have information on depression history and severity, and we lacked 
data on types of and compliance with treatment received including specific antidepressant medications, anti-psychot-
ics and other psychotropics, some of which have recently been shown to alter feedback loops with depression (and 
likely inflammation). [39] Given the reliance on discharge ICD-9/10 codes, it is likely patients with depression or other 
covariates were misclassified. Our study focused on a younger age cohort, one typically not evaluated in studies of 
influenza and lower respiratory infection. Similar studies may have different results in elderly cohorts. However, de-
fining depression in these older age groups could be challenging in the hospitalized patient. Finally, we did not have 
information on obesity status. Obesity is associated with nearly a two-fold increased risk for depression [40] and obe-
sity is significantly more prevalent in those with depression [41].  This association could influence our results because 
ULJRI | https://doi.org/10.18297/jri/vol4/iss2/1 7
ULJRI Depression is associated with decreased severity and lower mortality in non-elderly hospitalized adults with influenza in the United States
obesity is a known risk factor for severe influenza infection and increased mortality, since the 2009 H1N1 pandemic. 
[42, 43] Obesity may be an important effect modifier or have substantial interaction effects with depression due to the 
well-studied immune dysregulation in these patients. [28, 35] 
There are many areas of research that are needed in the field of depression and influenza infection. Larger databases 
with more complete and precise covariates needed for adjustment (e.g. influenza vaccination history, other comorbid 
conditions, anti-inflammatory medications, obesity) will be necessary to more fully document these potential associ-
ations. Although secondary analytics will continue to uncover clues into the relationships between this debilitating 
disease with risk of and outcomes of infection, prospective studies are needed. For example, understanding the base-
line inflammation of individuals prior to infection using novel causal machine learning models [44] may result in tar-
geted approaches to influenza prevention and management. Associations between intestinal or respiratory microbiota, 
depression, and infection may also be warranted to define other novel areas for therapy. Recently, changes in the gut 
microbiota have been documented in patients with depression [45], though the directional impact is still unknown. Re-
gardless, intestinal microbiota dysregulation increases systemic inflammation, and depression is preceded by systemic 
inflammation in some patients. [46-48] If gut microbiota induced systemic inflammation can trigger mood disorders, 
modulation of the gut microbiota may play a role in depression therapy and prevention of infection. [39]
In conclusion, this study suggests that in non-elderly hospitalized patients with influenza, depression is associated 
with a decreased severity of illness and acute mortality. Depression status may be an important marker of systemic 
inflammation critical to predicting clinical outcomes in these patients and should be evaluated more closely in more 
robust databases or prospective studies.
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